Understanding Ehlers-Danlos Syndromes (EDS)

Subtypes, symptoms, and prevalence

The Ehlers-Danlos syndromes (EDS) are a group of inherited conditions that affect connective tissue, the material that holds skin, joints, blood vessels, and organs together. Connective tissue is built largely from collagen. In EDS, the body either makes collagen incorrectly or has a problem with another protein that supports connective tissue.

Most types share a few features: joints that move beyond the normal range, skin that is soft, stretchy, or fragile, easy bruising, and slow or unusual wound healing. Connective tissue is everywhere in the body, so EDS can affect many systems, not just skin and joints.

The subtypes

The 2017 International Classification recognizes 13 subtypes. Each has its own features, severity, and, for all but one, a known genetic cause. One more type, AEBP1-related classical-like EDS (classical-like type 2), was described after 2017 and is not part of the formal 13. It is described last, for completeness.

*This data was obtained in 2026 and may change over time

Hypermobile (hEDS)

Inheritance: autosomal dominant / multi factorial

Genes: unknown; diagnosis is clinical

Symptoms: Generalized joint hypermobility, chronic joint pain, recurrent dislocations and subluxations, soft skin, fatigue, digestive problems. Often with anxiety, orthostatic intolerance, pelvic floor and bladder issues.

Estimated prevalence: Most common subtype, about 80 to 90% of EDS. With HSD, estimated near 1 in 300 to 500. hEDS alone estimated at least about 1 in 3,100 to 5,000.

Classical (cEDS)

Inheritance: autosomal dominant

Genes: COL5A1, COL5A2 (rarely COL1A1)

Symptoms: Very stretchy skin, wide thin "cigarette paper" scars, easy bruising, joint hypermobility, fragile skin, fleshy bumps near scars, small hard lumps under the skin.

Estimated prevalence: About 1 in 20,000.

Classical-like (clEDS)

Inheritance: autosomal recessive

Genes: TNXB

Symptoms: Stretchy, velvety skin without atrophic scarring, generalized hypermobility, easy bruising.

Estimated prevalence: Very rare, ~56 individuals reported cases

Vascular (vEDS)

Inheritance: autosomal dominant

Genes: COL3A1 (rarely COL1A1)

Symptoms: Thin translucent skin with visible veins, easy bruising, characteristic facial features, risk of spontaneous rupture of arteries, intestines, or the uterus in pregnancy. Most severe type. First major event often by age 20. Median survival about 51 years (roughly 49 in men, 53 in women), wide range.

Estimated prevalence: About 1 in 50,000 to 1 in 200,000.

Cardiac-valvular (cvEDS)

Inheritance: autosomal recessive

Genes: COL1A2 (biallelic null)

Symptoms: Severe heart valve disease (mitral, aortic), skin hyperextensibility, joint hypermobility, easy bruising, atrophic scarring.

Estimated prevalence: Very rare, ~7 reported cases

Arthrochalasia (aEDS)

Inheritance: autosomal dominant

Genes: COL1A1, COL1A2

Symptoms: Severe hypermobility, congenital bilateral hip dislocation, frequent dislocations, stretchy skin, easy bruising, low muscle tone.

Estimated prevalence: Very rare, ~30 reported cases

Dermatosparaxis (dEDS)

Inheritance: autosomal recessive

Genes: ADAMTS2

Symptoms: Extremely fragile skin that tears easily, severe bruising, loose sagging skin with redundant folds, hernias, delayed closure of fontanelles.

Estimated prevalence: Very rare, ~20 reported cases

Kyphoscoliotic (kEDS)

Inheritance: autosomal recessive

Genes: PLOD1, FKBP14

Symptoms: Low muscle tone at birth, progressive scoliosis, joint hypermobility, fragile eyes, easy bruising, risk of arterial rupture.

Estimated prevalence: Rare, ~ 1 in 100,000.

Brittle Cornea Syndrome (BCS)

Inheritance: autosomal recessive

Genes: ZNF469, PRDM5

Symptoms: Thin corneas at risk of rupture, progressive vision problems (keratoconus, keratoglobus), blue sclerae, joint hypermobility.

Estimated prevalence: Very rare, ~85 reported cases

Spondylodysplastic (spEDS)

Inheritance: autosomal recessive

Genes: B4GALT7, B3GALT6, SLC39A13

Symptoms: Short stature, low muscle tone, bowed limbs, stretchy and doughy skin, delayed motor development.

Estimated prevalence: Very rare ~35 reported cases

Musculocontractural (mcEDS)

Inheritance: autosomal recessive

Genes: CHST14, DSE

Symptoms: Congenital contractures of fingers and feet, hypermobility in other joints, stretchy skin, easy bruising, atrophic scarring, distinctive facial features.

Estimated prevalence: Very rare, ~80 reported cases

Myopathic (mEDS)

Inheritance: autosomal dominant or recessive

Genes: COL12A1

Symptoms: Muscle weakness from birth or early childhood, contractures in proximal joints, hypermobility in distal joints, soft doughy skin.

Estimated prevalence: Very rare, ~25 reported cases

Periodontal (pEDS)

Inheritance: autosomal dominant

Genes: C1R, C1S

Symptoms: Severe early gum disease and tooth loss, lack of attached gum tissue, skin fragility, easy bruising, joint hypermobility.

Estimated prevalence: Very rare, ~120 reported cases

AEBP1-related classical-like (clEDS2)

Inheritance: autosomal recessive

Genes: AEBP1

Symptoms: Stretchy skin, joint hypermobility, easy bruising, similar to classical EDS. Described after 2017, not part of the formal 13 subtypes.

Estimated prevalence: Very rare, ~15 reported cases

Learn more or get evaluated

Curious about hEDS and HSD, start here: hEDS vs HSD: What Is the Difference?

Anyone wondering whether they have hEDS, HSD or a different connective tissue disorder can book an hEDS evaluation.

Sources

1. Malfait F, Castori M, Francomano CA, et al. The Ehlers-Danlos syndromes. Nat Rev Dis Primers. 2020;6:64. PMID 32732924.

2. Yew KS, Kamps-Schmitt KA, Borge R. Hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Am Fam Physician. 2021;103(8):481-492.

3. Ritelli M, Chiarelli N, Cinquina V, et al. Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome. Am J Med Genet A. 2024.

4. Zoppi N, Chiarelli N, Binetti S, Ritelli M, Colombi M. Dermal fibroblast-to-myofibroblast transition sustained by avb3 integrin-ILK-Snail1/Slug signaling is a common feature for hEDS and HSD. Biochim Biophys Acta Mol Basis Dis. 2018. PMID 29309923.

5. Ritelli M, Chiarelli N, Cinquina V, et al. Bridging the diagnostic gap for hEDS and HSD: a common extracellular matrix fragmentation pattern in patient plasma as a potential biomarker. Am J Med Genet A. 2025. PMID 39225014.

6. MedlinePlus Genetics. Ehlers-Danlos syndrome. National Library of Medicine. 2022.

7. Forghani I, See J, McGonigle WC. Hypermobile Ehlers-Danlos syndrome: diagnostic challenges and the role of genetic testing. Genes (Basel). 2025;16:530. PMID 40428350.

8. Damseh N, Dupuis L, O'Connor C, et al. Diagnostic outcomes for molecular genetic testing in children with suspected Ehlers-Danlos syndrome. Am J Med Genet A. 2022;188(5):1376-1383. PMID 35128800.

9. Scicluna K, Formosa MM, Farrugia R, Borg I. Hypermobile Ehlers-Danlos syndrome: a review and a critical appraisal of published genetic research to date. Clin Genet. 2022;101(1):20-31.

10. Colman M, Syx D, De Wandele I, et al. Clinical and molecular characteristics of 168 probands and 65 relatives with a clinical presentation of classical Ehlers-Danlos syndrome. Hum Mutat. 2021. PMID 34265140.

11. Malfait F. Vascular aspects of the Ehlers-Danlos syndromes. Matrix Biol. 2018;71-72:380-395.

12. Samaraweera AP, Laverse E, Henderson A. Pearls & Oy-sters: vascular EDS presenting with acute proptosis. Neurology. 2016;87(4):e36-e38.

13. Martinez KL, Mauss C, Andrews J, et al. Subtle differences in autonomic symptoms in people diagnosed with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Am J Med Genet A. 2021;185(7):2012-2025.

Previous
Previous

Hypermobility Disorders Deserve Dedicated Care